For chemotherapy induced vomiting, 5HT3 antagonist having maximum potency is:
**Core Concept**
Chemotherapy-induced vomiting, also known as acute emesis, is a common side effect of cancer treatment. The 5HT3 antagonists are a class of medications that block the action of serotonin at the 5HT3 receptors in the brain, thereby preventing vomiting. The potency of these drugs can be measured by their ability to inhibit serotonin-induced emesis in animal models.
**Why the Correct Answer is Right**
The correct answer, **Ondansetron**, has the maximum potency among the 5HT3 antagonists. Ondansetron works by selectively blocking the 5HT3 receptors in the central nervous system, which are responsible for mediating nausea and vomiting. This is achieved through a competitive antagonism of the serotonin molecule at the receptor site, thereby reducing the emetic response. Ondansetron's high potency is attributed to its high affinity for the 5HT3 receptor and its ability to cross the blood-brain barrier, allowing it to effectively target the central nervous system.
**Why Each Wrong Option is Incorrect**
**Option A:** **Granisetron** is another 5HT3 antagonist, but it has a lower potency compared to ondansetron. Although it is still effective in preventing chemotherapy-induced vomiting, it requires higher doses to achieve the same level of efficacy as ondansetron.
**Option B:** **Alosetron** is a 5HT3 antagonist, but it is primarily used for the treatment of irritable bowel syndrome (IBS) rather than chemotherapy-induced vomiting. Its potency is also lower than ondansetron.
**Option C:** **Palonosetron** is a newer 5HT3 antagonist with a higher receptor binding affinity than ondansetron. However, its potency is not significantly higher than ondansetron, and it is primarily used for the prevention of delayed chemotherapy-induced nausea and vomiting.
**Clinical Pearl / High-Yield Fact**
When choosing an antiemetic for chemotherapy-induced vomiting, it's essential to consider the timing of the emetic response. Acute emesis typically occurs within 24 hours of chemotherapy, while delayed emesis occurs 24-120 hours after treatment. Ondansetron is effective for both acute and delayed emesis, making it a versatile choice in the management of chemotherapy-induced vomiting.
**Correct Answer: D. Ondansetron**